Pregabalin 300mg
Sponsors
GL Pharm Tech Corporation, Yousra Hisham Abdel Fattah, University of Missouri-Columbia, Hôpital Universitaire Fattouma Bourguiba, Universidade Federal de Alfenas
Conditions
Abuse PotentialAddictionAnalgesiaAnesthesiaAnesthesia MorbidityFibromyalgia, PrimaryGabapentin Adverse ReactionHealthy
Phase 1
Phase 2
Phase 3
Phase 4
Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy
TerminatedNCT04495374
Start: 2019-09-02End: 2020-09-30Updated: 2021-03-04
Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users
CompletedNCT05053126
Start: 2021-07-27End: 2022-04-01Updated: 2023-08-14